ePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Browsing publications by Dr David Sheridan

Newcastle Authors	Title	Year	Full text
Dr Simon Bridge Dr David Sheridan Dr R Neely Emeritus Professor Margaret Bassendine	Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?	2025
Dr David Sheridan Professor Stuart McPherson	National study of NAFLD management identifies variation in delivery of care in the UK between 2019-2022	2023
Professor David Jones Dr David Sheridan	A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis	2022
Dr David Sheridan Dr Daniel Felmlee Dr Simon Bridge Emeritus Professor Margaret Bassendine	Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis	2022
Dr David Sheridan Professor Quentin Anstee Professor Stuart McPherson	Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey	2017
Emeritus Professor Margaret Bassendine Dr Soren Nielsen Dr Simon Bridge Dr Daniel Felmlee Dr David Sheridan et al.	Hepatitis C virus and atherosclerosis: A legacy after virologic cure?	2017
Dr Luca Miele Dr David Sheridan	Diverse Impacts of the rs58542926 E167K Variant in TM6SF2 on Viral and Metabolic Liver Disease Phenotypes	2016
Dr David Sheridan	FibroGENE: A gene-based model for staging liver fibrosis	2016
Dr David Sheridan Fiona Fenwick Emeritus Professor Margaret Bassendine	Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection	2016
Professor Quentin Anstee Dr David Sheridan	Staging fibrosis and excluding advanced fibrosis in patients with NAFLD: comparison of non-invasive markers in an interim analysis from a prospective multicentre study	2016
Dr David Sheridan Professor Margaret Bassendine	Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease	2015
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Emeritus Professor Margaret Bassendine	Lipidomics analysis of fasting serum identifies novel lipid biomarkers specific for HCV genotype 3 and genotype 1 chronic hepatitis C virus infection	2015
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Fiona Fenwick Dr Clare Lanyon et al.	PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism	2015
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Dr R Neely Emeritus Professor Margaret Bassendine	Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency	2014
Dr David Sheridan Emeritus Professor Margaret Bassendine	Hepatitis C lipoviral particle levels are associated with spontaneous clearance of acute infection	2014
1 2 3